Data / Drug companies / Folate Analog
Folate Analog drugs: 6 drugs from 32 companies in the FDA NDC directory
Folate Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 110 products in this class from 32 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 14, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 32Companies
- 110Products
- 6Drugs by generic name
Drugs in the Folate Analog class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Leucovorin calcium | 62 | 18 |
| Levoleucovorin | 7 | 5 |
| Levoleucovorin injection | 4 | 2 |
| Calcium folinate | 2 | 2 |
| Folate, vitamin d3 | 1 | 2 |
| Levoleucovorin calcium | 2 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| PureTek Corporation | 14 | tablet; tablet, chewable | Other unapproved drugs | August 21, 2026 |
| Avion Pharmaceuticals, LLC | 8 | capsule, gelatin coated; tablet, coated | Other unapproved drugs | January 10, 2017 |
| Meitheal Pharmaceuticals Inc. | 7 | injection, powder, lyophilized, for solution; injection, solution | Generic drugs (ANDA) | July 19, 2023 |
| Slate Run Pharmaceuticals, LLC | 7 | injection, powder, lyophilized, for solution; injection, solution | Generic drugs (ANDA) | December 27, 2024 |
| BluePoint Laboratories | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 10, 2025 |
| Hikma Pharmaceuticals USA Inc. | 6 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 7, 2016 |
| Fresenius Kabi USA, LLC | 5 | injection, powder, lyophilized, for solution; injection | Generic drugs (ANDA) | July 27, 2018 |
| Hikma Pharmaceuticals USA Inc. | 5 | tablet | Generic drugs (ANDA) | February 22, 1993 |
| Sagent Pharmaceuticals | 5 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 15, 2018 |
| Carwin Pharmaceutical Associates, LLC | 4 | tablet, chewable; capsule, liquid filled | Other unapproved drugs | June 1, 2015 |
| Epic Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | January 1, 2021 |
| Gland Pharma Limited | 4 | injection, powder, lyophilized, for solution; injection | Generic drugs (ANDA) | October 14, 2026 |
| Ingenus Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | July 30, 2020 |
| Leading Pharma, LLC | 4 | tablet | Generic drugs (ANDA) | November 16, 2020 |
| Avyxa Pharma, LLC | 3 | injection | New drug applications (NDA) | March 16, 2026 |
| Mylan Institutional LLC | 3 | injection, powder, lyophilized, for suspension | Generic drugs (ANDA) | July 23, 2019 |
| Dr. Reddy's Laboratories Inc. | 2 | injection, solution | Generic drugs (ANDA) | September 26, 2018 |
| Exeltis USA, Inc. | 2 | capsule, liquid filled | Other unapproved drugs | March 15, 2020 |
| Hainan Poly Pharm. Co., Ltd. | 2 | injection, solution | Generic drugs (ANDA) | May 31, 2023 |
| Jaymac Pharmaceuticals, LLC | 2 | capsule, delayed release pellets; capsule | Other unapproved drugs | August 1, 2024 |
| Teva Pharmaceuticals USA, Inc. | 2 | tablet | Generic drugs (ANDA) | June 30, 1990 |
| Acella Pharmaceuticals, LLC | 1 | tablet | Other unapproved drugs | May 25, 2021 |
| Acrotech Biopharma Inc | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | January 2, 2019 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | February 17, 2017 |
| Amneal Pharmaceuticals LLC | 1 | injection, solution | Generic drugs (ANDA) | September 8, 2017 |
| Farmasierra Manufacturing SL | 1 | tablet | Unapproved drugs for a shortage | November 26, 2025 |
| Glenmark Pharmaceuticals Inc., USA | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 12, 2025 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | March 27, 2026 |
| Oncora Pharma, LLC | 1 | tablet, chewable | Other unapproved drugs | April 7, 2026 |
| Pfizer Laboratories Div Pfizer Inc | 1 | tablet | Unapproved drugs for a shortage | December 18, 2025 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | November 16, 2020 |
| Skya Health, LLC | 1 | capsule, gelatin coated | Other unapproved drugs | September 4, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, lyophilized, for solution | 35 | 31.8% |
| Tablet | 35 | 31.8% |
| Injection, solution | 8 | 7.3% |
| Tablet, chewable | 8 | 7.3% |
| Injection | 7 | 6.4% |
| Capsule, gelatin coated | 4 | 3.6% |
| Capsule | 4 | 3.6% |
| Injection, powder, lyophilized, for suspension | 3 | 2.7% |
| Capsule, liquid filled | 3 | 2.7% |
| Tablet, coated | 1 | 0.9% |
| Capsule, delayed release pellets | 1 | 0.9% |
| Tablet, film coated | 1 | 0.9% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.